Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
156 hedge funds and large institutions have $1.36B invested in Exact Sciences in 2014 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 61 increasing their positions, 44 reducing their positions, and 25 closing their positions.
48% more capital invested
Capital invested by funds: $916M → $1.36B (+$441M)
39% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 44
36% more call options, than puts
Call options by funds: $59.6M | Put options by funds: $43.9M
20% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 25
3% more funds holding
Funds holding: 151 → 156 (+5)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$46.5M |
| 2 |
Primecap Management
Pasadena,
California
|
+$34.3M |
| 3 |
William Blair & Company
Chicago,
Illinois
|
+$30.6M |
| 4 |
Tiger Global Management
New York
|
+$27.5M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$17.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$12.7M |
| 2 |
6CM
683 Capital Management
New York
|
-$12.4M |
| 3 |
Goldman Sachs
New York
|
-$8.11M |
| 4 |
D.E. Shaw & Co
New York
|
-$7.4M |
| 5 |
SI
Stephens Inc
Little Rock,
Arkansas
|
-$4.4M |
EXAS Hedge Fund Activity: Q2 2014 in Review
156 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q2 2014, worth a combined $1.36B — up 48% from $916M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new EXAS positions and 25 closed out — a net gain of 5 holders — while 61 added to existing stakes and 44 trimmed.
The largest buyer was Capital Research Global Investors, opening a new position worth an estimated $46.5M. The largest seller was Perceptive Advisors, cutting an estimated $12.7M.
- 156 institutional investors held Exact Sciences (EXAS) as of Q2 2014, up from 151 in Q1 2014.
- Funds reported $1.36B of Exact Sciences stock for Q2 2014, up 48% quarter-over-quarter.
- 30 funds opened new Exact Sciences positions in Q2 2014 and 25 closed out, a net change of +5 holders.
- The largest Exact Sciences buyer in Q2 2014 was Capital Research Global Investors, an estimated $46.5M added.
- The largest Exact Sciences seller in Q2 2014 was Perceptive Advisors, an estimated $12.7M sold.
Based on aggregated 13F filings for Q2 2014.